Explore more publications!
LATAM Technology Reporter
Got News to Share?

LATAM Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on January 28, 2026

Ryoncil® Net Revenues Increase for the Quarter to US$30M
Jan. 28, 2026

Ryoncil® Net Revenues Increase for the Quarter to US$30M

Indeterminate GlobeNewswire
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split
Jan. 28, 2026

Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split

Indeterminate GlobeNewswire
Prostar Announces Upsizing of Convertible Debenture Financing
Jan. 28, 2026

Prostar Announces Upsizing of Convertible Debenture Financing

Indeterminate GlobeNewswire
UAGC Faculty Leader Advances National Conversation on AI and Faculty Development
Jan. 28, 2026

UAGC Faculty Leader Advances National Conversation on AI and Faculty Development

Indeterminate EIN Presswire
Fake dating app used as lure in spyware campaign targeting Pakistan, ESET Research discovers
Jan. 28, 2026

Fake dating app used as lure in spyware campaign targeting Pakistan, ESET Research discovers

Indeterminate GlobeNewswire
1317202 B.C. Ltd. and Titiminas Silver Inc. Announces Execution of Business Combination Agreement and $25 Million Financing
Jan. 28, 2026

1317202 B.C. Ltd. and Titiminas Silver Inc. Announces Execution of Business Combination Agreement and $25 Million Financing

Indeterminate GlobeNewswire
Elevar Therapeutics Submits New Drug Application to FDA for Lirafugratinib as Second-Line Treatment Option for Cholangiocarcinoma
Jan. 28, 2026

Elevar Therapeutics Submits New Drug Application to FDA for Lirafugratinib as Second-Line Treatment Option for Cholangiocarcinoma

Indeterminate GlobeNewswire
InEight Document Completes IRAP Assessment at PROTECTED Level, Giving Australian Public Sector Added Assurances on Security
Jan. 28, 2026

InEight Document Completes IRAP Assessment at PROTECTED Level, Giving Australian Public Sector Added Assurances on Security

Indeterminate GlobeNewswire
NVIDIA Sets Conference Call for Fourth-Quarter Financial Results
Jan. 28, 2026

NVIDIA Sets Conference Call for Fourth-Quarter Financial Results

Indeterminate GlobeNewswire
AXO Copper Corp. Announces $25M Bought Deal Financing of Units
Jan. 28, 2026

AXO Copper Corp. Announces $25M Bought Deal Financing of Units

Indeterminate GlobeNewswire
Inuvo Appoints Rob Buchner as Chairman and Chief Executive Officer
Jan. 28, 2026

Inuvo Appoints Rob Buchner as Chairman and Chief Executive Officer

Indeterminate GlobeNewswire
AMERICAN REBEL HOLIDNGS, INC. (NASDAQ: AREB; AREBW) REANNOUNCES 1-FOR-20 REVERSE STOCK SPLIT OF ITS COMMON STOCK AND PUBLICLY TRADED WARRANTS WITH ROUND LOT STOCKHOLDER PROTECTION TO BE EFFECTIVE ON FEBRUARY 2, 2026
Jan. 28, 2026

AMERICAN REBEL HOLIDNGS, INC. (NASDAQ: AREB; AREBW) REANNOUNCES 1-FOR-20 REVERSE STOCK SPLIT OF ITS COMMON STOCK AND PUBLICLY TRADED WARRANTS WITH ROUND LOT STOCKHOLDER PROTECTION TO BE EFFECTIVE ON FEBRUARY 2, 2026

Indeterminate GlobeNewswire
Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease
Jan. 28, 2026

Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease

Indeterminate GlobeNewswire
Inuvo Reports Unaudited Preliminary Fourth Quarter 2025 Revenue Results
Jan. 28, 2026

Inuvo Reports Unaudited Preliminary Fourth Quarter 2025 Revenue Results

Indeterminate GlobeNewswire
Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting
Jan. 28, 2026

Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting

Indeterminate GlobeNewswire
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
Jan. 28, 2026

Amneal Pharmaceuticals Added to S&P SmallCap 600® Index

Indeterminate GlobeNewswire
Aeluma to Announce Second Quarter of Fiscal Year 2026 Financial Results on February 11, 2026
Jan. 28, 2026

Aeluma to Announce Second Quarter of Fiscal Year 2026 Financial Results on February 11, 2026

Indeterminate GlobeNewswire
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update
Jan. 28, 2026

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire
Illumio Named a Customers’ Choice in Gartner Peer Insights™ Voice of the Customer for Network Security Microsegmentation
Jan. 28, 2026

Illumio Named a Customers’ Choice in Gartner Peer Insights™ Voice of the Customer for Network Security Microsegmentation

Indeterminate GlobeNewswire
Top AI-powered Vehicle Inspection Alternative to Uveye: How Elscope Vision Advanced Vision Enhances Workshop Accuracy
Jan. 28, 2026

Top AI-powered Vehicle Inspection Alternative to Uveye: How Elscope Vision Advanced Vision Enhances Workshop Accuracy

Indeterminate EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions